event tracking

Epigenetics

125 results.

November 22, 2015 Van Andel Research Institute professor elected as an AAAS Fellow

GRAND RAPIDS, Mich. (Nov. 23, 2015)—Van Andel Research Institute’s Gerd Pfeifer, Ph.D., has been named a Fellow of the…

November 17, 2015 Van Andel Research Institute’s Hui Shen receives ovarian cancer research award

GRAND RAPIDS, Mich. (Nov. 18, 2015)—The Ovarian Cancer Research Fund (OCRF) announced yesterday that Van Andel Research Institute (VARI)

November 15, 2015 Van Andel Research Institute expands into new areas of Parkinson’s research

GRAND RAPIDS, Mich. (Nov. 16, 2015)—Van Andel Research Institute (VARI) is continuing the expansion of its neurodegenerative disease research program, which aims to answer fundamental…

VAI DEFAULT HEADER
November 4, 2015 TCGA findings provide molecular background for second most common kidney cancer

GRAND RAPIDS, Mich. (Nov. 5, 2015)—Scientists with The Cancer Genome Atlas (TCGA), a National Institutes of Health-funded project, have…

VAI DEFAULT HEADER
August 26, 2015 Researchers thwart cancer cells by triggering 'virus alert'

Note: This press release was written by John Hopkins Medicine. Dr. Stephen Baylin, who holds a joint appointment at Van Andel Research Institute (VARI) and at…

VAI DEFAULT HEADER
August 26, 2015 Researchers mimic viral infection in colon cancer stem cells, identify druggable target to potentially root out disease, end relapse

Note: This press release was written by Princess Margaret Cancer Centre. Dr. Peter Jones, Van Andel Research Institute’s (VARI) research director, is a contributing author on…

July 22, 2015 New antibody specificity portal bolsters biomedical research reliability

UNC’s Brian Strahl and Van Andel Research Institute’s Scott Rothbart create a robust online interactive database to address science’s ‘antibody crisis’.

GRAND RAPIDS,…

VAI DEFAULT HEADER
February 25, 2015 Van Andel Research Institute appoints leading cancer scientist Dr. Stephen Baylin as professor

GRAND RAPIDS, Mich. (Feb. 26, 2015)—Renowned cancer scientist and epigenetics expert Stephen Baylin, M.D., has accepted an appointment at Van Andel Research Institute (VARI) to help…